Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Gellér L[Au]:

Search results

Items: 1 to 20 of 527

1.

Cardiac magnetic resonance based deformation imaging: role of feature tracking in athletes with suspected arrhythmogenic right ventricular cardiomyopathy.

Czimbalmos C, Csecs I, Dohy Z, Toth A, Suhai FI, Müssigbrodt A, Kiss O, Geller L, Merkely B, Vago H.

Int J Cardiovasc Imaging. 2018 Oct 31. doi: 10.1007/s10554-018-1478-y. [Epub ahead of print]

PMID:
30382474
2.

Application of "AL-FINE CRT" risk score before cardiac resynchronisation therapy implantation.

Kosztin A, Boros AM, Geller L, Merkely B.

Kardiol Pol. 2018;76(10):1418-1419. doi: 10.5603/KP.2018.0205. No abstract available.

3.

Acute, total occlusion of the left main stem: coronary intervention options, outcomes, and recommendations.

Édes IF, Ruzsa Z, Lux Á, Gellér L, Molnár L, Nowotta F, Kerülő MC, Becker D, Merkely B.

Postepy Kardiol Interwencyjnej. 2018;14(3):233-239. doi: 10.5114/aic.2018.78325. Epub 2018 Sep 21.

4.

Cardiac resynchronisation therapy: current benefits and pitfalls.

Kosztin A, Boros AM, Geller L, Merkely B.

Kardiol Pol. 2018;76(10):1420-1425. doi: 10.5603/KP.a2018.0160. Epub 2018 Aug 9.

PMID:
30091132
5.

Repetitive narrow QRS tachycardia in a 61-year-old female patient with recent palpitations.

Vereckei A, Gellér L.

J Geriatr Cardiol. 2018 Feb;15(2):193-198. doi: 10.11909/j.issn.1671-5411.2018.02.012. No abstract available.

6.

Novel Biomarkers in Cardiac Resynchronization Therapy: Hepatocyte Growth Factor Is an Independent Predictor of Clinical Outcome.

Perge P, Boros AM, Szilágyi S, Zima E, Molnár L, Gellér L, Prohászka Z, Merkely B, Széplaki G.

Rev Esp Cardiol (Engl Ed). 2019 Jan;72(1):48-55. doi: 10.1016/j.rec.2017.12.015. Epub 2018 Mar 23. English, Spanish.

PMID:
29580749
7.

The impact of the left ventricular pacing polarity and localization during cardiac resynchronization therapy on depolarization and repolarization parameters.

Özcan EE, Öztürk A, Özel E, Senarslan Ö, Merkely B, Geller L.

Anatol J Cardiol. 2018 Apr;19(4):237-242. doi: 10.14744/AnatolJCardiol.2018.62357. Epub 2018 Mar 21.

8.

Intratumoral bacteria may elicit chemoresistance by metabolizing anticancer agents.

Geller LT, Straussman R.

Mol Cell Oncol. 2017 Dec 11;5(1):e1405139. doi: 10.1080/23723556.2017.1405139. eCollection 2018.

9.

Pacemaker-Mediated Programmable Hypertension Control Therapy.

Neuzil P, Merkely B, Erglis A, Marinskis G, de Groot JR, Schmidinger H, Rodriguez Venegas M, Voskuil M, Sturmberger T, Petru J, Jongejan N, Aichinger J, Kamzola G, Aidietis A, Gellér L, Mraz T, Osztheimer I, Mika Y, Evans S, Burkhoff D, Kuck KH; BackBeat Study Investigators.

J Am Heart Assoc. 2017 Dec 23;6(12). pii: e006974. doi: 10.1161/JAHA.117.006974.

10.

Quality of life measured with EuroQol-five dimensions questionnaire predicts long-term mortality, response, and reverse remodelling in cardiac resynchronization therapy patients.

Nagy KV, Széplaki G, Perge P, Boros AM, Kosztin A, Apor A, Molnár L, Szilágyi S, Tahin T, Zima E, Kutyifa V, Gellér L, Merkely B.

Europace. 2018 Sep 1;20(9):1506-1512. doi: 10.1093/europace/eux342.

11.

Blepharochalasis: A rare cause of eye swelling.

Paul M, Geller L, Nowak-Węgrzyn A.

Ann Allergy Asthma Immunol. 2017 Nov;119(5):402-407. doi: 10.1016/j.anai.2017.07.036. Review. No abstract available.

PMID:
29150067
12.

De novo implantation vs. upgrade cardiac resynchronization therapy: a systematic review and meta-analysis.

Kosztin A, Vamos M, Aradi D, Schwertner WR, Kovacs A, Nagy KV, Zima E, Geller L, Duray GZ, Kutyifa V, Merkely B.

Heart Fail Rev. 2018 Jan;23(1):15-26. doi: 10.1007/s10741-017-9652-1.

13.

Importance of anticoagulation and postablation silent cerebral lesions: Subanalyses of REVOLUTION and reMARQable studies.

Grimaldi M, Swarup V, DeVille B, Sussman J, Jaïs P, Gaita F, Duytschaever M, Ng GA, Daoud E, Lakkireddy DD, Horton R, Wickliffe A, Ellis C, Geller L.

Pacing Clin Electrophysiol. 2017 Dec;40(12):1432-1439. doi: 10.1111/pace.13205. Epub 2017 Nov 15.

PMID:
28975641
14.

Clinical presentation at first heart failure hospitalization does not predict recurrent heart failure admission.

Kosztin A, Costa J, Moss AJ, Biton Y, Nagy VK, Solomon SD, Geller L, McNitt S, Polonsky B, Merkely B, Kutyifa V.

ESC Heart Fail. 2017 Nov;4(4):520-526. doi: 10.1002/ehf2.12157. Epub 2017 Jun 17.

15.

The impact of cardiac resynchronization therapy on routine laboratory parameters.

Boros AM, Perge P, Nagy KV, Apor A, Bagyura Z, Zima E, Molnár L, Tahin T, Becker D, Gellér L, Merkely B, Széplaki G.

Interv Med Appl Sci. 2017 Mar;9(1):1-8. doi: 10.1556/1646.9.2017.1.01.

16.

Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine.

Geller LT, Barzily-Rokni M, Danino T, Jonas OH, Shental N, Nejman D, Gavert N, Zwang Y, Cooper ZA, Shee K, Thaiss CA, Reuben A, Livny J, Avraham R, Frederick DT, Ligorio M, Chatman K, Johnston SE, Mosher CM, Brandis A, Fuks G, Gurbatri C, Gopalakrishnan V, Kim M, Hurd MW, Katz M, Fleming J, Maitra A, Smith DA, Skalak M, Bu J, Michaud M, Trauger SA, Barshack I, Golan T, Sandbank J, Flaherty KT, Mandinova A, Garrett WS, Thayer SP, Ferrone CR, Huttenhower C, Bhatia SN, Gevers D, Wargo JA, Golub TR, Straussman R.

Science. 2017 Sep 15;357(6356):1156-1160. doi: 10.1126/science.aah5043.

17.

The Impact of Cryoballoon Versus Radiofrequency Ablation for Paroxysmal Atrial Fibrillation on Healthcare Utilization and Costs: An Economic Analysis From the FIRE AND ICE Trial.

Chun KRJ, Brugada J, Elvan A, Gellér L, Busch M, Barrera A, Schilling RJ, Reynolds MR, Hokanson RB, Holbrook R, Brown B, Schlüter M, Kuck KH; FIRE AND ICE Investigators.

J Am Heart Assoc. 2017 Jul 27;6(8). pii: e006043. doi: 10.1161/JAHA.117.006043. Erratum in: J Am Heart Assoc. 2017 Sep 15;6(9):.

18.

Assessment of Infantile Hemangiomas Using a Handheld Wireless Diffuse Optical Spectroscopic Device.

Fong CJ, Garzon MC, Hoi JW, Kim HK, Lauren CT, Morel K, Geller L, Antonov N, Weitz N, Wu J, Hielscher AH.

Pediatr Dermatol. 2017 Jul;34(4):386-391. doi: 10.1111/pde.13150. Epub 2017 May 26.

19.

The Financial Impact of Advanced Kidney Disease on Canada Pension Plan and Private Disability Insurance Costs.

Manns B, McKenzie SQ, Au F, Gignac PM, Geller LI; Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease (Can-SOLVE CKD) Network.

Can J Kidney Health Dis. 2017 Apr 17;4:2054358117703986. doi: 10.1177/2054358117703986. eCollection 2017.

20.

Porokeratotic eccrine ostial and dermal duct nevus: a unique case treated with CO2 laser.

Zade J, Jfri A, Nabatian A, Alajaji A, Geller L, Khorasani H.

Clin Case Rep. 2017 Mar 31;5(5):675-678. doi: 10.1002/ccr3.846. eCollection 2017 May.

Supplemental Content

Loading ...
Support Center